STS01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STS01, covering 2024-05-07 to 2024-05-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) [Phase 2]